FREMONT, Calif., April 09, 2018 -- Identiv, Inc. (NASDAQ:INVE) today announced that it will present the Company’s portfolio of radio frequency identification (RFID), near field communication (NFC), and inlay solutions during RFID Journal LIVE! 2018 in Orlando, FL. RFID Journal LIVE! is the world's largest event focused on RFID and related technologies.
| Event: | RFID Journal LIVE! 2018 | |
| Date: | April 10 - 12, 2018 | |
| Location: | Booth 1038 | Orange County Convention Center | Orlando, FL |
Identiv’s team of experts focus on the design and manufacture of embedded high-frequency (HF) and ultra high-frequency (UHF) transponders for objects, such as medical devices, books, toys, athletic apparel, and perishable food items and pharmaceuticals. Identiv’s RFID, NFC, and inlay portfolio of solutions feature various transponder form factors, including dry inlays, wet inlays, labels, tickets, and more. These transponders are uniquely positioned to deliver RFID connectivity to any object in the Internet of Things (IoT) market. Applications range from brand authenticity, consumer engagement, and item level tracking to tamper detection, embedded sensors, and others.
Identiv’s customer, AUM Cardiovascular, has been named finalist for the Best RFID Implementation in Health Care category for the 12th Annual RFID Journal Awards. During the awards presentations on Thursday, April 12th, VP and R&D of AUM Cardiovascular Dr. Jixing Yao will present a live demonstration of the AUM Cardiovascular CADence System, a non-invasive handheld acoustic and ECG device that helps physicians detect physiological and pathological heart murmurs. Using RFID technology, Identiv’s HIPPA-compliant intelligent inlays protect patient privacy by de-identifying sensitive information stored in the single-use patient booklets that come with the CADence System.
Visit Identiv experts onsite in booth 1038 at RFID Journal LIVE! 2018 on April 10 - 12, 2018 at Orange County Convention Center in Orlando, Florida, or book a meeting today.
About Identiv
Identiv, Inc. is a global provider of physical security and secure identification. Identiv’s products, software, systems, and services address the markets for physical and logical access control, video analytics and a wide range of RFID-enabled applications. Customers in the government, enterprise, consumer, education, healthcare, banking, retail, and transportation sectors rely on Identiv’s access and identification solutions. Identiv's mission is to secure the connected physical world: from perimeter to desktop access, and from the world of physical things to the Internet of Everything. Identiv is a publicly traded company and its common stock is listed on the NASDAQ Capital Market in the U.S. under the symbol “INVE.” For more information, visit identiv.com.
Identiv Media Contact:
[email protected]


FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Amazon Explores AI Content Marketplace With Media Publishers
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



